Physician profile
Floyd Anthony Richard
NPI 1063416592
$4,697.70
in general payments reported to CMS, 2019-2025
24 companies · $1,000 in 2025
The $1,000 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $1,347 · 2021: $502 · 2022: $697 · 2023: $63.48 · 2024: $970 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,800 · Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,800.00 |
| Food and Beverage | $233.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $1,800.00 | 2024-2025 | Bovine Collagen |
| Intuitive Surgical, INC. | $1,294.89 | 2019-2020 | |
| Avion Pharmaceuticals | $390.28 | 2021-2022 | |
| Abbvie INC. | $384.78 | 2019-2023 | |
| Aspira Women'S Health INC | $244.28 | 2022-2024 | Ova1 |
| Mylan Pharmaceuticals INC. | $69.48 | 2021-2022 | |
| Astellas Pharma US INC | $62.43 | 2024 | Veozah |
| Coopersurgical, INC. | $58.39 | 2019-2021 | |
| Pfizer INC. | $54.68 | 2020-2024 | |
| Mayne Pharma Commercial LLC | $45.92 | 2021-2023 | |
| Gynesonics, INC. | $43.72 | 2022 | |
| Channel Medsystems, INC. | $41.15 | 2022 | |
| Ethicon US, LLC | $25.40 | 2022 | |
| Exeltis, USA INC. | $23.67 | 2022 | |
| Scynexis, INC. | $23.24 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $22.86 | 2020 | |
| Biogen, INC. | $19.51 | 2024 | Zurzuvae |
| Exact Sciences Corporation | $17.74 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $17.31 | 2022 | |
| Evofem Biosciences, INC. | $14.52 | 2021 | |
| Agile Therapeutics, INC. | $14.12 | 2022 | |
| Allergan, INC. | $14.03 | 2019 | |
| Lupin INC. | $12.06 | 2019 | |
| Organon LLC | $3.24 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Floyd Richard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.